The GLOW 70mg vial contains BPC-157 10mg (pentadecapeptide GEPPPGKPADDAGLV, CHNO, 1419.53 g/mol, CAS 137525-51-0), TB-500 10mg (synthetic thymosin beta 4, 43 residues N-terminally acetylated, CHNOS, 4963.4 g/mol, CAS 77591-33-4) and GHK-Cu 50mg (glycyl-L-histidyl-L-lysine copper(II) complex, CHCuNO, 403.9 g/mol, CAS 89030-95-5), co-lyophilised in a single container
If medication is right for you, well craft a custom dosing schedule and ship your treatment straight to your door, through a certified, state-licensed pharmacy
Most patients experience the most intense nausea during the titration phasethe period when your doctor gradually raises your dose every four weeks to reach a maintenance level
Influence on healing and protection : BPC-157 is known for its role in supporting recovery in various tissues, including muscles, blood vessels, and the digestive system
Glucagon-like peptide-1 receptor agonist exendin-4 mitigates lipopolysaccharide-induced inflammatory responses in RAW264.7 macrophages
